Community Health Workers and Drugs: A Case Study of Thailand - EDM Research Series No. 015
(1994; 78 pages)

Índice de contenido

Acknowledgements
List of abbreviations
Summary
Chapter 1. Introduction
Chapter 2. Community health workers, village drug funds, and the Thai primary health care programme
	2.1 The evolution of the Thai primary health care programme
	2.2 The VHV and VHC in the Thai PHC programme
	2.3 The village drug funds (VDFs)
	2.4 The drug provision role of the VDF
		2.4.1 Operational forms of the VDFs
		2.4.2 The VDF role in drug provision
Chapter 3. The village drug provision profile
	3.1 The village drug provision profiles (VDPP): an overview
	3.2 Drugs in the villages: range and types
	3.3 Major sources of drugs
Chapter 4. Community drug use
	4.1 Tracer illnesses and treatment/drug choice
	4.2 Drugs used during the tracer illness episodes
	4.3 Other health problems and the demand for drugs
Chapter 5. Conclusions and recommendations
	5.1 Conclusions
	5.2 Recommendations
Notes
Bibliography
List of annexes
	Annex 1: Tables
	Annex 2: List of household drugs
	Annex 3: Methodology
Other documents in the DAP Research Series

Community Health Workers and Drugs: A Case Study of Thailand - EDM Research Series No. 015

Action Programme on Essential Drugs
World Health Organization

WHO/DAP/94.19
English only
Distribution: Limited

World Health Organization
Organisation mondiale de la Santé

IMPLICATIONS OF
COMMUNITY HEALTH WORKERS
DISTRIBUTING DRUGS

A case study of Thailand

Action Programme on Essential Drugs

Luechai Sringernyuang (1)
Thavitong Hongvivatana (1)
Penchan Pradabmuk (1)

(1) Center for Health Policy Studies, Mahidol University, Bangkok, Thailand

Much research work, particularly in developing countries, at present goes unreported. The reasons for this include the intense competition to publish in the scientific press, and difficulties in matching the research resources of developed countries. The DAP research series was established to provide a forum for the rapid distribution of data and findings relevant to critical areas of drug policy and use. The Action Programme has a firm commitment to national operational research as part of its direct country support. It is also strongly committed to making the findings of such studies widely known and accessible. While every effort is made by the Programme to support studies of the highest possible quality, research skills and resources will vary from country to country. Documents in the DAP research series reflect this variation, and range from reports of very small scale studies, undertaken with minimal resources, to major global research involving substantive financial, scientific and editorial input.

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).

The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO

The views expressed in documents by named authors are solely the responsibility of those authors.